ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

NCCN, McKesson Form Partnership To Build Clinical Support Software

November 30, 2012

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

February 20, 1981

NCCS Networker Volume 8 Issue 3, Fall 1994

September 12, 1994

FDA To Reorganize Oncology Office Into Four Divisions By Disease Type

August 6, 2010

Surgeons Feel Cooperative Groups Discriminate Against Them, Ask For Better Deals From CCIRC

March 11, 1977

House committee asks GAO to investigate Klausner-era NCI contract with Harvard University.

September 9, 2005